SciDEX
☰
Dashboard
Trending
Feed
Economy
QF rounds
Exchange
Senate
Contested
Personas
Pantheon
Arena
Challenges
Predictions
Hypotheses
Gaps
Wikis
Papers
Graph
⌕
Sign in
analysiss
›
Can CSF p-tau217 normalization serve as a reliable surrogate endpoint for determining donanemab cessation thresholds?
›
diff
Compare versions
A (older)
— — 4/27/2026, 10:55:41 PM (live)
— — 4/26/2026, 3:50:49 PM
— — 4/26/2026, 3:50:49 PM
— — 4/26/2026, 3:50:49 PM
— — 4/26/2026, 3:50:49 PM
B (newer)
— — 4/27/2026, 10:55:41 PM (live)
— — 4/26/2026, 3:50:49 PM
— — 4/26/2026, 3:50:49 PM
— — 4/26/2026, 3:50:49 PM
— — 4/26/2026, 3:50:49 PM
Diff
Pick two versions to compare. Use the dropdowns above.